Blueprint Medicines Reports Second Quarter 2018 Financial Results

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/21/2026

1. SPCX
2. NVDA
3. NFLX
4. ISRG
5. TSLA
6. META
7. RTX
8. SMCI
9. GOOGL
10. S

Go back to Blueprint Medicines Reports Second Quarter 2018 Financial Results

Blueprint Medicines (BPMC) Reports Q2 Loss of $0.62/Share

August 1, 2018 7:11 AM EDT

Blueprint Medicines (NASDAQ: BPMC) reported Q2 EPS of ($0.62), versus ($0.86) reported last year. Revenue for the quarter came in at $41.44 million, versus $5.89 million reported last year.

For earnings history and earnings-related data on Blueprint Medicines (BPMC) click here.

... More